Literature DB >> 10092989

Lack of interleukin 10 regulation of antigen presentation-associated molecules expressed on colonic epithelial cells.

A Bourreille1, J P Segain, D Raingeard de la Blétière, S Siavoshian, G Vallette, J P Galmiche, H M Blottière.   

Abstract

BACKGROUND: Colonic epithelial cells may behave as antigen-presenting cells. Interleukin 10 (IL-10) is known to play a major role in the intestinal immune system; however, it remains to be determined whether human intestinal epithelial cells express IL-10 receptor, and whether this cytokine modulates their expression of antigen presentation-associated molecules.
METHODS: The binding of biotinylated IL-10 was studied in SW 1116, HT-29 and T84 human colonic epithelial cell lines and freshly isolated normal colonic epithelial cells. Reverse transcription-polymerase chain reaction was also performed to detect IL-10 receptor mRNA. The effect of IL-10 on antigen presentation associated molecules was assessed by flow cytometry.
RESULTS: Biotinylated IL-10 bound to SW 1116, HT-29, T84, and normal colonic epithelial cells. IL-10 receptor mRNA was detected in SW 1116 and normal epithelial cells. SW 1116 and HT-29 cells expressed MHC class I and ICAM-1, but not CD80, and SW 1116 constitutively expressed HLA-DR. Interferon-gamma up-regulated HLA-DR and ICAM-1 expression on both cells, whereas lipopolysaccharide increased ICAM-1 expression only on SW 1116. IL-10 failed to modulate these antigens, even after stimulation by lipopolysaccharide or interferon-gamma. Moreover, these molecules decreased IL-10 binding in both lines.
CONCLUSION: The presence of IL-10 receptor on intestinal epithelial cells suggest that IL-10 may play a role in mucosal physiology, however its effect on the immune response remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092989     DOI: 10.1046/j.1365-2362.1999.00410.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

Review 1.  Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.

Authors:  Dror S Shouval; Jodie Ouahed; Amlan Biswas; Jeremy A Goettel; Bruce H Horwitz; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

2.  Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency.

Authors:  Andreas G Moraitis; Lita A Freeman; Robert D Shamburek; Robert Wesley; Wyndham Wilson; Cliona M Grant; Susan Price; Stephen Demosky; Seth G Thacker; Abdalrahman Zarzour; Ronald L Hornung; Frank Pucino; Gyorgy Csako; Cheryl Yarboro; Iain B McInnes; Takashi Kuroiwa; Dimitrios Boumpas; V Koneti Rao; Gabor G Illei; Alan T Remaley
Journal:  J Clin Lipidol       Date:  2014-10-05       Impact factor: 4.766

3.  IL-10 gene therapy is therapeutic for dextran sodium sulfate-induced murine colitis.

Authors:  J O Lindsay; A Sandison; P Cohen; F M Brennan; H J F Hodgson
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

4.  IFN-γ-mediated induction of an apical IL-10 receptor on polarized intestinal epithelia.

Authors:  Douglas J Kominsky; Eric L Campbell; Stefan F Ehrentraut; Kelly E Wilson; Caleb J Kelly; Louise E Glover; Colm B Collins; Amanda J Bayless; Bejan Saeedi; Evgenia Dobrinskikh; Brittelle E Bowers; Christopher F MacManus; Werner Müller; Sean P Colgan; Dunja Bruder
Journal:  J Immunol       Date:  2013-12-23       Impact factor: 5.422

5.  Microbial-Derived Butyrate Promotes Epithelial Barrier Function through IL-10 Receptor-Dependent Repression of Claudin-2.

Authors:  Leon Zheng; Caleb J Kelly; Kayla D Battista; Rachel Schaefer; Jordi M Lanis; Erica E Alexeev; Ruth X Wang; Joseph C Onyiah; Douglas J Kominsky; Sean P Colgan
Journal:  J Immunol       Date:  2017-09-11       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.